» Articles » PMID: 16574712

MDMA Polydrug Users Show Process-specific Central Executive Impairments Coupled with Impaired Social and Emotional Judgement Processes

Overview
Publisher Sage Publications
Specialty Pharmacology
Date 2006 Apr 1
PMID 16574712
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years working memory deficits have been reported in users of MDMA (3,4-methylenedioxymethamphetamine, ecstasy). The current study aimed to assess the impact of MDMA use on three separate central executive processes (set shifting, inhibition and memory updating) and also on "prefrontal" mediated social and emotional judgement processes. Fifteen polydrug ecstasy users and 15 polydrug non-ecstasy user controls completed a general drug use questionnaire, the Brixton Spatial Anticipation task (set shifting), Backward Digit Span procedure (memory updating), Inhibition of Return (inhibition), an emotional intelligence scale, the Tromso Social Intelligence Scale and the Dysexecutive Questionnaire (DEX). Compared with MDMA-free polydrug controls, MDMA polydrug users showed impairments in set shifting and memory updating, and also in social and emotional judgement processes. The latter two deficits remained significant after controlling for other drug use. These data lend further support to the proposal that cognitive processes mediated by the prefrontal cortex may be impaired by recreational ecstasy use.

Citing Articles

Decoding Emotion in Drug Abusers: Evidence for Face and Body Emotion Recognition and for Disgust Emotion.

Bonfiglio N, Renati R, Bottini G Eur J Investig Health Psychol Educ. 2022; 12(9):1427-1440.

PMID: 36135237 PMC: 9498236. DOI: 10.3390/ejihpe12090099.


In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings.

Moore D, Turner J, Goodwin J, Fulton S, Singer L, Parrott A Clin Dev Med. 2022; 188:169-182.

PMID: 35422536 PMC: 9007183.


Meta-analysis of executive functioning in ecstasy/polydrug users.

Roberts C, Jones A, Montgomery C Psychol Med. 2016; 46(8):1581-96.

PMID: 26966023 PMC: 4873937. DOI: 10.1017/S0033291716000258.


MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.

Parrott A, Moore D, Turner J, Goodwin J, Min M, Singer L Hum Psychopharmacol. 2014; 29(1):1-7.

PMID: 24424703 PMC: 10187755. DOI: 10.1002/hup.2342.


Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.

Turner J, Parrott A, Goodwin J, Moore D, Fulton S, Min M J Psychopharmacol. 2013; 28(1):55-61.

PMID: 24327452 PMC: 5111163. DOI: 10.1177/0269881113515061.